Skip to main content
LobbyMap

Eli Lilly and Company

Pharmaceutical & Health Products · Lobbying Client

B
Influence Score
68/100
High Influence
$22.9M
Total Lobby Spend
6
Policy Issues
9
Lobbyists
4
Revolving Door

Eli Lilly and Company reported $22.9 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Interior
White House
Small Business Administration
Dept of Housing & Urban Development
Dept of Treasury
Dept of Labor
US Senate

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarSquire Patton Boggs LLP
PHA
3$1.1M
2020 Apr-JunHolland & Knight LLP
TAXCPT
2$1.2M
2020 Jul-SepBrownstein Hyatt LLP
PHAHCRTAX+2
2$1.1M
2020 Oct-DecAkin Gump LLP
PHA
2$1.0M
2021 Jan-MarBGR Group LLP
MEDCPTTAX+2
3$648K
2021 Apr-JunSquire Patton Boggs LLP
TAXPHAMED
2$954K
2021 Jul-SepBGR Group LLP
GOVPHA
2$869K
2021 Oct-DecSquire Patton Boggs LLP
GOVCPTMED+2
1$1.0M

Eli Lilly and Company Lobbying FAQ

Eli Lilly and Company has spent $22.9M on federal lobbying across 6 policy areas. This includes spending on registered lobbyists and direct government contacts.

Eli Lilly and Company lobbies on 6 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Copyright/Patent/Trademark. These disclosures are filed quarterly with the Senate Office of Public Records.

Eli Lilly and Company has an Influence Score of 68/100 (Grade B). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Eli Lilly and Company employs 9 registered lobbyists, of whom 4 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Eli Lilly and Company has contacted 7 government entities as part of their lobbying activities, including Dept of Interior, White House, Small Business Administration.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.